Impact of changes in weight and haematocrit on the reduction in systolic office and ambulatory blood pressure with empagliflozin in patients with type 2 diabetes
27 August 2021 (00:00 - 00:00)
Organised by:
About the speaker
McGill University Health Centre, Montreal (Canada)
46 More presentations in this session
Doctor V. Razuk (New York City, US)
Doctor G. Steiner-Gager (Vienna, AT)
Doctor L. Uthman (Nijmegen, NL)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
27 August - 30 August 2021
You may be interested in
Congress Presentation
Congress Presentation
